To further validate these results, the 6 F6 mAb was tested in other cancer cell lines that overexpress CLDN1 (BXPC3, PANC-1, SKOV-3, IGROV1 and HuH-7 cells) (Additional file 2: Figure S3 and Fig. 4b). The gene discussed is CLDN1; the disease is cancer.